Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search
Simple search

Simple search

*
(*) mandatory field




 

Other search option(s)

147 matching term(s)

Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Biochemical diagnosis of congenital adrenal hyperplasia (21-hydroxylase, 11-hydroxylase, 3-beta-hydroxysteroid dehydrogenase)
    • Laboratoire Cerba
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
    • Labor Lademannbogen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, CYP17A1, HSD3B2 genes)
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 genes: sequencing, MLPA)
    • Pränatalmedizin München
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Medizinisches Versorgungszentrum Humane Genetik
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÖNCHENGLADBACH
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Medizinische Versorgungszentrum Dr.Stein + Kollegen
    • More information
    • GERMANY
    • Bayern
    • NEU-ULM
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Paxis und Labor Dr. med Karl Mehnert
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Medizinisch Genetisches Zentrum München
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (CYP21A2 gene: Diagnosis available by NIPD (non-invasive pre-natal diagnostic) / post-natal targetted mutation analysis)
    • St Mary's Hospital
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene): analysis of the entire coding region
    • Instituto de Biologia Molecular e Celular
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN-EDEGEM
    • Accreditation
    • Molecular diagnosis of Congenital adrenal hyperplasia (CYP21 gene)
    • University and University Hospital of Antwerp - UZA
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Biochemical diagnosis of Congenital adrenal hyperplasia (Analytes: 17 hydroxyprogesterone, renin, aldosterone, DHEAS & urine steroid profiles)
    • UCL Hospitals
    • More information
    • UNITED KINGDOM
    • Merseyside
    • LIVERPOOL
    • Accreditation
    • Molecular diagnosis of Sex Determination For X-Linked Conditions For Disorders That Manifest Significantly Different In One Sex Compared To The Other by Targetted Mutation and Copy Number Analysis (Genes: AMELX, AMELY, SRY)
    • Liverpool Women's NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (CYP21A2 gene)
    • Birmingham Women's NHS Foundation Trust
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
    • Gemeinschaftspraxis Dr. Prager / Dr. Junge / Dr. Hennig / Dr. Linné
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Molecular Diagnosis of Male Infertility Due To Y Chromosome Deletions (DDX3Y, DAZ1, DAZ2, DAZ3, USP9Y genes: targeted mutation analysis)
    • Salisbury District Hospital
    • More information
    • GERMANY
    • Hessen
    • BAD NAUHEIM
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Centrum für Humangenetik
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
    • GenteQ GmbH
    • More information
    • GERMANY
    • Baden-Württemberg
    • MANNHEIM
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes)
    • Zentrum für Humangenetik Mannheim
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: sequencing / MLPA; CYP11B1, HSD3B2, POR genes: sequencing)
    • Universitätsklinikum Regensburg
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of Male Infertility Due To Y Chromosome Deletions (DDX3Y, DAZ1, DAZ2, DAZ3, USP9Y genes: Targetted mutation analysis / Testing for known mutations in family members)
    • St George's University of London
    • More information
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (CYP21A2 gene)
    • Radboudumc - Radboud universitair medisch centrum
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • ZÜRICH
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency ( CYP21A2 gene)
    • Institut für Medizinische & Molekulare Diagnostik AG
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CY11B1, CYP21A2, HSD3B2 genes)
    • Praxis für Humangenetik Freiburg
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (DAX1 analysis)
    • International Centre for Life
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (NR0B1 gene: Sequencing of the entire coding region of gene (s) / Testing for known mutations in family members)
    • International Centre for Life
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: APEX and MPLA)
    • Asper Biotech Ltd.
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1genes)
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, HSD3B2 genes)
    • Centogene AG
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Universitätsklinikum Heidelberg
    • More information
    • GERMANY
    • Baden-Württemberg
    • KARLSRUHE
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Labor PD Dr. Volkmann und Kollegen
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN
    • Accreditation
    • Neonatal screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (17-OH-progesterone: GSP (Delfia method), bloodspots)
    • Provinciaal Centrum voor opsporing van Metabole Aandoeningen (PCMA) - Antwerpen
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: sequencing / MLPA)
    • MVZ Labor Dr. Reising-Ackermann und Kollegen
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • Zentrum für Humangenetik
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, HSD3B2 genes)
    • MVZ Fenner & Krasemann
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Neonatal screening : Biochemical diagnosis of congenital adrenal hyperplasia
    • Universitätsklinikum Carl Gustav Carus an der TU Dresden
    • More information
    • UNITED KINGDOM
    • West Yorkshire
    • LEEDS
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (MLPA for dosage/genomic rearrangements plus analysis of common point mutations, CYP21A2 gene)
    • St James's University Hospital
    • More information
    • UNITED KINGDOM
    • West Yorkshire
    • LEEDS
    • Accreditation
    • Molecular Diagnosis of Male Infertility Due To Y Chromosome Deletions (DDX3Y, DAZ1, DAZ2, DAZ3, USP9Y genes: targeted mutation analysis / Testing for known mutations in family members)
    • St James's University Hospital
    • More information
    • UNITED KINGDOM
    • Hampshire
    • SOUTHAMPTON
    • Accreditation
    • Biochemical diagnosis of Congenital Adrenal Hyperplasia, due to 21-hydroxylase deficiency, classic form (Analyte: 17-hydroxyprogesterone)
    • Southampton General Hospital
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Accreditation
    • Preimplantation genetic diagnosis of the congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Sistemas Genómicos S.L.
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • IFLb Laboratoriumsmedizin Berlin GmbH
    • More information
    • FRANCE
    • RHONE-ALPES
    • GRENOBLE
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Grenoble site Nord - Institut de biologie et de pathologie
    • More information
    • FRANCE
    • RHONE-ALPES
    • BRON
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CHU de Lyon-GH Est - Hospices Civils de Lyon
    • More information
    • FRANCE
    • RHONE-ALPES
    • BRON
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Lyon-GH Est - Hospices Civils de Lyon
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Neonatal screening of congenital adrenal hyperplasia
    • CHRU de Lille - Centre de biologie pathologie génétique
    • More information
    • FRANCE
    • BASSE-NORMANDIE
    • CAEN
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Caen - Hôpital de la Côte de Nacre
    • More information
    • ITALY
    • PIEMONTE
    • TORINO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Biotecnologie Avanzate Srl
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Praxis für medizinische Genetik
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (mutations in CYP21A2 gene)
    • Hospital Universitario Central de Asturias
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A1 gene)
    • Laboratorio Genoma
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • ESSEN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 genes)
    • Laborärztlich-humangenetische Partnerschaft Eiben - Glaubitz
    • More information
    • ITALY
    • SARDEGNA
    • CAGLIARI
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • Ospedale Regionale per le Microcitemie
    • More information
    • SPAIN
    • Galicia
    • SANTIAGO DE COMPOSTELA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, CYP17A1, HSD3B2 genes)
    • CHUS - Complejo Hospitalario Universitario de Santiago
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • IRCCS Ospedale San Raffaele
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • CHU Paris Centre - Hôpital Cochin
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene): analysis of the entire coding region and UTR 5' and deletion/duplication analysis.
    • Faculdade de Medicina da Universidade do Porto
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of the congenital adrenal hyperplasia (CYP21A2 gene)
    • Sistemas Genómicos S.L.
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, CYP11B1, HSD3B2 genes)
    • Praxis Dres. Gencik
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Klinikum Stuttgart - Standort Olgahospital
    • More information
    • DENMARK
    • Hovedstaden
    • COPENHAGEN
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene: copy number estimation and complete sequencing)
    • Rigshospitalet
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of Adrenogenital syndrome (CYP11B1, CYP17A1, CYP21A2, and HSD3B2 genes)
    • Praxis für Humangenetik
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Hospital Clínic de Barcelona
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Hospital Materno Infantil Gregorio Marañón
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (CYP21A2 gene)
    • The Cyprus Institute of Neurology and Genetics
    • More information
    • BELGIUM
    • LIEGE
    • LIEGE
    • Neonatal screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (17-OH-progesterone: ELISA, bloodspots)
    • CHU Sart Tilman - Liège
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene): Target mutation analysis - panel of mutations (P30L, 659A>G, 8bp DEL, I172N, e6 cluster, V281L, F306+t, Q318X, R356W, P453S) and sequence analysis of the entire coding region and deletion/duplication analysis by MLPA
    • CGC Genetics / Centro de Genética Clínica
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Preimplantation genetic diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Reprogenetics Spain S.A.
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene / MLPA, mutations panel)
    • Centro Inmunológico de Alicante (CIALAB)
    • More information
    • NORWAY
    • Østlandet
    • OSLO
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Oslo University Hospital, Ullevaal
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of congenital adrenal hyperplasia
    • Acibadem healthcare group
    • More information
    • HUNGARY
    • Észak-Magyarország
    • BUDAPEST
    • Molecular diagnosis of congenital adrenal hyperplasia by allele-specific amplification (CYP21A2 gene)
    • Semmelweis University
    • More information
    • SLOVENIA
    • SLOVENIA
    • MARIBOR
    • Molecular diagnosis of congenital adrenal hyperplasia
    • Maribor general hospital
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • More information
    • SWEDEN
    • Stockholms läns landsting
    • STOCKHOLM
    • Molecular diagnosis of congenital adrenal hyperplasia 11-beta-hydroxylase, 17-alpha-hydroxylase, 17-beta-hydroxylase, 21-beta-hydroxylase (HSD3B2, CYP11B1, CYP17A1, HSD17B3, CYP21A2 genes)
    • Karolinska University Hospital - Solna
    • More information
    • SWEDEN
    • Stockholms läns landsting
    • STOCKHOLM
    • Molecular diagnosis of congenital adrenal hyperplasia (STAR gene)
    • Karolinska University Hospital - Solna
    • More information
    • ITALY
    • VENETO
    • VERONA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Azienda Ospedaliera Universitaria Integrata di Verona - Ospedale Borgo Roma
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BONN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes)
    • Institut für Klinische Genetik Bonn
    • More information
    • SLOVENIA
    • SLOVENIA
    • LJUBLJANA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • University Medical Centre Ljubljana
    • More information
    • AUSTRIA
    • TIROL
    • INNSBRUCK
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, HSD3B2 and POR genes)
    • Medizinische Universität Innsbruck
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1 and CYP17A1 genes)
    • Hospital Universitario La Paz
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
    • Diagenom GmbH
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Molecular diagnosis of congenital adrenal hyperplasia (CY11B1 and HSD3B2 genes: sequencing; CYP21A2 gene: sequencing / MLPA)
    • Pränatalzentrum Hamburg und Humangenetik
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of congenital adrenal hyperplasia. CYP21A2 and CYP11B genes.
    • Genetaq
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of congenital adrenal hyperplasia. HSD3B2 gene.
    • Genetaq
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, classic form (CYP21A2 gene)
    • Genetaq
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of congenital adrenal hyperplasia (Analysis of mutations in CYP21A2 coding region)
    • Nzoz Genomed
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • IMEGEN - Instituto de Medicina Genómica
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Molecular diagnosis of congenital adrenal hyperplasia (CY11B1 and HSD3B2 genes: sequencing, CYP21A2 gene: sequencing/ MLPA)
    • Molekulargenetisches Labor der Gemeinschaftspraxis
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Reims - American Memorial Hospital
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • ViennaLab Diagnostics
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • MVZ Humangenetik Ulm
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: sequencing / MLPA)
    • Gemeinschaftspraxis für Humangenetik
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Preimplantation genetic diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CME Barcelona
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CIBIR - Centro de Investigación Biomédica de La Rioja
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of congenital adrenal hyperplasia (Analysis of mutations in CYP21A2 coding region)
    • MEDGEN
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Hospital Universitari General Vall d'Hebron
    • More information
    • SPAIN
    • Castilla - León
    • SALAMANCA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene / sequencing)
    • Universidad de Salamanca. Facultad de Medicina
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of congenital adrenal hyperplasia (HSD3B2 and CYP21A2 genes)
    • Allgemeines Krankenhaus
    • More information
    • CANADA
    • Alberta
    • CALGARY
    • Molecular Diagnosis of Congenital Adrenal Hyperplasia (sequence analysis and MLPA of CYP21A2 coding regions)
    • Alberta Children's Hospital
    • More information
    • FRANCE
    • ALSACE
    • STRASBOURG
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Strasbourg - Hôpital Civil
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • ANGERS
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU d'Angers
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • NANTES
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Nantes - Hôpital Mère-Enfant
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU Paris - Hôpital Robert Debré
    • More information
    • FRANCE
    • BOURGOGNE
    • DIJON
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Dijon - Plateau technique de Biologie
    • More information
    • FRANCE
    • BOURGOGNE
    • DIJON
    • Biochemical diagnosis of congenital adrenal hyperplasia
    • CHU de Dijon - Plateau technique de Biologie
    • More information
    • FRANCE
    • AQUITAINE
    • PESSAC
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Bordeaux-GH Sud - Hôpital Haut-Lévêque
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Neonatal screening of congenital adrenal hyperplasia
    • Centre régional de dépistage néonatal
    • More information
    • FRANCE
    • FRANCHE-COMTE
    • BESANÇON
    • Neonatal screening of congenital adrenal hyperplasia
    • CHRU de Besançon - Hôpital Saint-Jacques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Biochemical diagnosis of congenital adrenal hyperplasia (21-hydroxylase, 11-hydroxylase, 17-hydroxylase, 3 beta hydroxysteroid deshydrogenase deficiency)
    • CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Saint-Louis
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of 21-hydroxylase deficiency (CYP21A2 gene)
    • Azienda Ospedaliera S. Camillo-Forlanini
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Azienda Ospedaliera Universitaria "Federico II"
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Ospedale Niguarda Ca' Granda
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Praxis Dr. med. Ulrike Beudt
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia. CYP17A1 gene
    • Fundació Institut de Recerca Hospital Universitari Vall d'Hebron
    • More information
    • GERMANY
    • Hessen
    • GIEßEN
    • Diagnostics and monitoring of steroid related disorders by gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry (steroid metabolomics)
    • Universitätsklinikum Gießen und Marburg GmbH, Standort Gießen
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Hospital de la Santa Creu i Sant Pau
    • More information
    • ITALY
    • SICILIA
    • PALERMO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • Azienda Ospedaliera Ospedali Riuniti "Villa Sofia-Cervello"
    • More information
    • IRELAND
    • Leinster
    • DUBLIN
    • Biochemical diagnosis of congenital adrenal hyperplasia
    • Mater Misericordiae Hospital
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ
    • Biochemical diagnosis of congenital adrenal hyperplasia
    • Spitalul de Pediatrie Copii Cluj
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ
    • Molecular and biochemical diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 11-betahydroxylase deficiency
    • U.M.F. Iuliu Hatieganu Cluj
    • More information
    • LEBANON
    • Beyrouth
    • BEIRUT
    • Molecular diagnosis of congenital adrenal hyperplasia (complete CYP21A2 gene sequencing)
    • Université Saint-Joseph
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • BOLOGNA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • Azienda Ospedaliera di Bologna - Policlinico S. Orsola-Malpighi
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (sequencing and MLPA of CYP21A2 gene)
    • DNA Data
    • More information
    • CZECH REPUBLIC
    • South Moravia
    • BRNO
    • Postnatal and prenatal molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • University hospital Brno
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Newborn screening : Biochemical diagnosis of congenital adrenal hyperplasia
    • Universitätsklinikum Heidelberg
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Biochemical diagnosis of congenital adrenal hyperplasia
    • Ospedale dei Bambini ''Vittore Buzzi"
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (CYP21A2, Linkage analysis, PGD)
    • Shaare Zedek Medical Center
    • More information
    • NETHERLANDS
    • Utrecht
    • BILTHOVEN
    • Newborn screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (Analyte: 17-Hydroxyprogesterone)
    • RIVM - Rijksinstituut voor Volksgezondheid en Milieu
    • More information
    • UNITED KINGDOM
    • County Antrim
    • BELFAST
    • Biochemical diagnosis of Congenital Adrenal Hyperplasia, due to 21-hydroxylase deficiency, classic form (Analyte: 17-hydroxyprogesterone)
    • Royal Group of Hospitals Belfast
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Biochemical diagnosis of Congenital Adrenal Hyperplasia
    • Clinical Sciences Building (CSB3)
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • The Children's Memorial Health Institute CMHI (IP-CZD)
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: allele-specific PCR and sequencing)
    • "Aghia Sophia" Children's Hospital
    • More information
    • FINLAND
    • Finland
    • KUOPIO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • University of Eastern Finland
    • More information
    • SPAIN
    • Andalucía
    • ARMILLA
    • Molecular diagnosis of congenital adrenal hyperplasia (entire coding sequence of CYP11B1, CYP17A1, CYP21A2 and HSD3B2 genes)
    • Lorgen G.P.
    • More information
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Molecular diagnosis of congenital adrenal hyperplasia
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2, CYP17A1, HSD3B2 genes: sequencing))
    • ATG GenMed GmbH
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Preimplantation genetic diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Iviomics SL
    • More information
    • SPAIN
    • Andalucía
    • CAMPANILLAS
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene / sequencing, real-time PCR (7 mutations), MLPA)
    • GenoClinics
    • More information
    • SLOVAKIA
    • Bratislavsky kraj
    • BRATISLAVA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (nested PCR, RT-PCR, MLPA, SnaPshot, fragmentation and sequencing analysis of CYP21A2 gene in blood and amniotic fluid)
    • University Hospital Bratislava - Stare mesto
    • More information
    • SPAIN
    • Comunidad Valenciana
    • ALICANTE
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene / sequencing mutations)
    • Instituto Bernabeu Biotech
    • More information
    • CROATIA
    • CROATIA
    • ZAGREB
    • Molecular diagnosis of Congenital Adrenal Hyperplasia
    • Children's University Hospital Zagreb
    • More information